Press release
Drug-Resistant Epilepsy Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | PTC Therapeutics, MGC Pharmaceuticals, iQure Pharma, ES Therapeutics, PhytoTech Therapeutics, UCB Biopharma
To Know in detail about the Drug-Resistant Epilepsy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Drug-Resistant Epilepsy Market Forecast
https://www.delveinsight.com/sample-request/drug-resistant-epilepsy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Drug-Resistant Epilepsy Market Report:
• The Drug-Resistant Epilepsy market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• Refractory epilepsy will eventually develop in about one-third of patients with epilepsy. This indicates that medications are either ineffective at controlling seizures altogether
• According to a study by Sirven et al. (2020) titled "Evaluation and management of drug-resistant epilepsy," up to about 20-40% of epilepsy patients (or over 400,000 persons living in the US) may have refractory epilepsy
• Key Drug-Resistant Epilepsy Companies: PTC Therapeutics, MGC Pharmaceuticals, iQure Pharma, ES Therapeutics, PhytoTech Therapeutics, UCB Biopharma, SK Life Science, Inc., Marinus Pharmaceuticals, Zogenix, Inc., and others
• Key Drug-Resistant Epilepsy Therapies: Vatiquinone, MGCND00EP1, iQ-007, ES-481, PLT101, UCB0942, RWJ-333369, Padsevonil, ataluren, ganaxolone, Fenfluramine, and others
• The Drug-Resistant Epilepsy market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Drug-Resistant Epilepsy pipeline products will significantly revolutionize the Drug-Resistant Epilepsy market dynamics.
Drug-Resistant Epilepsy Overview
Drug-resistant epilepsy, also known as intractable epilepsy or refractory epilepsy, is characterized by the inability to control seizures after adequate trials with two antiepileptic medication regimes that were well tolerated, wisely selected, and utilized (either as monotherapy or in combination).
Get a Free sample for the Drug-Resistant Epilepsy Market Report
https://www.delveinsight.com/report-store/drug-resistant-epilepsy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Drug-Resistant Epilepsy Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Drug-Resistant Epilepsy Epidemiology Segmentation:
The Drug-Resistant Epilepsy market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Drug-Resistant Epilepsy
• Prevalent Cases of Drug-Resistant Epilepsy by severity
• Gender-specific Prevalence of Drug-Resistant Epilepsy
• Diagnosed Cases of Episodic and Chronic Drug-Resistant Epilepsy
Download the report to understand which factors are driving Drug-Resistant Epilepsy epidemiology trends @ Drug-Resistant Epilepsy Epidemiology Forecast
https://www.delveinsight.com/sample-request/drug-resistant-epilepsy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Drug-Resistant Epilepsy Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Drug-Resistant Epilepsy market or expected to get launched during the study period. The analysis covers Drug-Resistant Epilepsy market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Drug-Resistant Epilepsy Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Drug-Resistant Epilepsy Therapies and Key Companies
• Vatiquinone: PTC Therapeutics
• MGCND00EP1: MGC Pharmaceuticals
• iQ-007: iQure Pharma
• ES-481: ES Therapeutics
• PLT101: PhytoTech Therapeutics
• UCB0942: UCB Biopharma
• RWJ-333369: SK Life Science, Inc.
• Padsevonil: UCB Biopharma
• ataluren: PTC Therapeutics
• ganaxolone: Marinus Pharmaceuticals
• Fenfluramine: Zogenix, Inc.
Discover more about therapies set to grab major Drug-Resistant Epilepsy market share @ Drug-Resistant Epilepsy Treatment Market
https://www.delveinsight.com/sample-request/drug-resistant-epilepsy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Drug-Resistant Epilepsy Market Strengths
• Growing Focus On Providing Seizure-Free Life To Fuel Innovations.
• Growth in The Demand For Epileptic Seizures Treatment
Drug-Resistant Epilepsy Market Opportunities
• Growing funding for R&D of epilepsy is also contributing as a factor for the market growth.
• Rising neurological diseases among population will also propel the growth of the market increasing brain injuries cases due to road accidents will also drive the growth of this market
Scope of the Drug-Resistant Epilepsy Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Drug-Resistant Epilepsy Companies: PTC Therapeutics, MGC Pharmaceuticals, iQure Pharma, ES Therapeutics, PhytoTech Therapeutics, UCB Biopharma, SK Life Science, Inc., Marinus Pharmaceuticals, Zogenix, Inc., and others
• Key Drug-Resistant Epilepsy Therapies: Vatiquinone, MGCND00EP1, iQ-007, ES-481, PLT101, UCB0942, RWJ-333369, Padsevonil, ataluren, ganaxolone, Fenfluramine, and others
• Drug-Resistant Epilepsy Therapeutic Assessment: Drug-Resistant Epilepsy current marketed and Drug-Resistant Epilepsy emerging therapies
• Drug-Resistant Epilepsy Market Dynamics: Drug-Resistant Epilepsy market drivers and Drug-Resistant Epilepsy market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Drug-Resistant Epilepsy Unmet Needs, KOL's views, Analyst's views, Drug-Resistant Epilepsy Market Access and Reimbursement
To know more about Drug-Resistant Epilepsy companies working in the treatment market, visit @ Drug-Resistant Epilepsy Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/drug-resistant-epilepsy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Drug-Resistant Epilepsy Market Report Introduction
2. Executive Summary for Drug-Resistant Epilepsy
3. SWOT analysis of Drug-Resistant Epilepsy
4. Drug-Resistant Epilepsy Patient Share (%) Overview at a Glance
5. Drug-Resistant Epilepsy Market Overview at a Glance
6. Drug-Resistant Epilepsy Disease Background and Overview
7. Drug-Resistant Epilepsy Epidemiology and Patient Population
8. Country-Specific Patient Population of Drug-Resistant Epilepsy
9. Drug-Resistant Epilepsy Current Treatment and Medical Practices
10. Drug-Resistant Epilepsy Unmet Needs
11. Drug-Resistant Epilepsy Emerging Therapies
12. Drug-Resistant Epilepsy Market Outlook
13. Country-Wise Drug-Resistant Epilepsy Market Analysis (2019-2032)
14. Drug-Resistant Epilepsy Market Access and Reimbursement of Therapies
15. Drug-Resistant Epilepsy Market Drivers
16. Drug-Resistant Epilepsy Market Barriers
17. Drug-Resistant Epilepsy Appendix
18. Drug-Resistant Epilepsy Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Drug-Resistant Epilepsy Pipeline https://www.delveinsight.com/report-store/drug-resistant-epilepsy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Drug-Resistant Epilepsy Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Drug-Resistant Epilepsy market. A detailed picture of the Drug-Resistant Epilepsy pipeline landscape is provided, which includes the disease overview and Drug-Resistant Epilepsy treatment guidelines.
Drug-Resistant Epilepsy Epidemiology https://www.delveinsight.com/report-store/drug-resistant-epilepsy-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Drug-Resistant Epilepsy Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Drug-Resistant Epilepsy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Non-invasive Prenatal Testing Market https://www.delveinsight.com/report-store/non-invasive-prenatal-testing-market
Non-Invasive Prenatal Testing Market By Product Type (Instruments And Kits And Reagents), By Indication (Down Syndrome, Edwards Syndrome, Patau Syndrome, Turner Syndrome, And Others), By End-User (Hospitals, Diagnostic Labs, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of chromosomal disorders and the increasing demand for early and non-invasive fetal diagnosis across the globe.
Orthopedic Implants Market https://www.delveinsight.com/report-store/orthopedic-implants-market
Orthopedic Implants Market By Product Type (Hip Implants, Knee Implants, Spinal Implants, Foot And Ankle Implants, And Others), By End-User (Hospitals, Orthopedic Clinics, And Others ), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to increasing prevalence of orthopedic diseases and rising demand for personalized orthopedic implants.
Analgesics Market
https://www.delveinsight.com/report-store/analgesics-market
Analgesics Market By Product Type (Opioid And Non-Opioid), By Application (Musculoskeletal, Surgical And Trauma, Cancer, And Others), By Drug Type (Prescription And Over-The-Counter (Otc)) By Distribution Channels (Hospital Pharmacy & Retail Pharmacy, And E-Commerce) by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to the increasing prevalence of orthopedic, cancer, and other chronic diseases and rising demand of analgesics for the treatment of mild to moderate pain.
Animal Nutrition Market
https://www.delveinsight.com/report-store/animal-nutrition-market
Animal Nutrition Market By Product Type (Amino Acids, Enzymes, Vitamins And Minerals, Medicated Feed Additives, Antioxidants, And Others), By Animal Type (Poultry, Ruminant, Pet Food, And Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to rising awareness on animal health and nutrition and increasing industrialisation of livestock production.
Point of Care Diagnostics Market
https://www.delveinsight.com/report-store/point-of-care-diagnostics-market
Point of Care Diagnostics Market By Product Type (Instruments, Kits And Reagents), By Application (Blood Glucose Monitoring, Infectious Diseases, Cardio-Metabolic Diseases, Pregnancy & Fertility Testing, And Others), By End-User (Hospitals, Diagnostic Centers, Home Care Settings, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of infectious and other lifestyle based disorders such as diabetes and cardiovascular diseases and growing awareness on health.
Hyaluronic Acid Viscosupplementation Market
https://www.delveinsight.com/report-store/hyaluronic-acid-viscosupplementation-market
The Hyaluronic Acid Viscosupplementation Market By Treatment Type (Single Injection, Three Injections, And Five Injections), By End-User (Hospitals, Specialty Clinics, And Others), And By Geography Is Expected To Grow At A Steady CAGR forecast till 2028 owing to the increasing prevalence of osteoarthritis, particularly among the geriatric population and increasing demand for non-surgical treatment options for osteoarthritis.
Frozen Food Market
https://www.delveinsight.com/report-store/frozen-food-market
Frozen Foods Market By Product (Fruits & Vegetables, Dairy Products, Meat Products, Seafood Products, And Others), By Product Type (Raw Material, Half-Cooked And Ready-To-Eat), By Distribution Channel (Hypermarkets And Supermarkets, General Stores, E-Commerce, And Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to rise in the demand for ready-to-eat dishes, overall increase in the average income of individuals, rising work culture in countries, lack of time, usage of foods for extended period and others, along with the rising advancements in delivering quality and preservative-free frozen foods across the globe.
Intrauterine Pressure Catheters Market
https://www.delveinsight.com/report-store/intrauterine-pressure-catheters-market
Intrauterine Pressure Catheters Market By Product (Fluid-Filled Catheters And Transducer Tip Catheters), By End-User (Hospitals, Ambulatory Surgical Centers (ASCS), And Specialty Clinics), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the growing number complications in pregnancy and rising focus on maternal and fetal care across the globe.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drug-Resistant Epilepsy Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | PTC Therapeutics, MGC Pharmaceuticals, iQure Pharma, ES Therapeutics, PhytoTech Therapeutics, UCB Biopharma here
News-ID: 3261150 • Views: …
More Releases from DelveInsight Business Research
Global Tumor Ablation Market to reach USD 4,595.68 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The global Tumor Ablations (EHR) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases that require continuous monitoring, data management, and coordinated long-term care. This demand has fueled the need for integrated healthcare systems capable of connecting patient information across multiple departments and care settings. To support this trend, governments worldwide are introducing initiatives, funding, mandates, and regulatory frameworks to promote EHR…
Global Spinal Implants Market to reach USD 21,899.24 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing prevalence of spinal disorders, especially among the aging population, has substantially driven the demand for corrective surgical procedures. At the same time, the rise in sports-related and trauma-induced spinal injuries is boosting the need for advanced implantable solutions. Additionally, there is a growing preference for non-fusion and motion-preserving devices that maintain spinal mobility and improve patient outcomes, particularly among younger and more active individuals.…
Global Vascular Stents Market to reach USD 18,277.68 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing global incidence of cancer is boosting the demand for effective treatment options such as tumor ablation. Minimally invasive procedures are becoming more popular due to their shorter recovery periods, reduced risks, and cost-effectiveness compared to conventional surgery. At the same time, technological advancements in tumor ablation devices-such as improvements in radiofrequency, microwave, and cryoablation technologies-have enhanced precision, safety, and effectiveness, making these procedures increasingly…
Global Vascular Grafts Market to reach USD 3,153.39 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The increasing prevalence of cardiovascular disorders, along with risk factors like hypertension, diabetes, and obesity, is fueling the demand for surgical interventions, thereby supporting the growth of the vascular graft market. Moreover, greater awareness and the expansion of cardiovascular screening programs are enabling earlier diagnosis and timely treatment, further driving the need for vascular grafts.
DelveInsight's "Vascular Grafts Market Insights, Competitive Landscape and Market Forecast-2032" report provides…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
